DRMA:NASDAQ, Dermata Therapeutics, Inc.

DRMA stock overview

Dermata Therapeutics, Inc. (DRMA:NASDAQ) closed at $0.860 on October 16, 2026, down 5.49% on the day. The stock trades 81.5% below its 52-week high of $4.66 and 42.6% above its 52-week low of $0.603. Over the past year, it lost 78.3%. Dermata Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$0.860
Day change
-5.49%
Volume
2,493,710
Average volume
3,365,276
Market cap
4M+
52-week range
$0.603 – $4.66
50-day average
$1.21
200-day average
$1.39

Performance

5D 1M 3M 6M 1Y
-3.33% -25.86% -32.28% -35.82% -78.34%

Price action over the past year

In 252 trading sessions since October 16, 2025, DRMA closed higher on 100 days (40%). Its best day was February 19, 2026 (+50.78%) and its worst was February 20, 2026 (-30.05%). The stock moved 10% or more in a single session 30 times. It opened at least 5% above the previous day's high 5 times.

Recent signals

DRMA news

About Dermata Therapeutics, Inc.

Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.

Similar stocks

Find more stocks like DRMA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.